Peptide Knowledge Base · Metabolic
Tirzepatide: what it is, what the evidence says, and its real status
A dual GIP/GLP-1 medicine with the strongest weight and metabolic trial data in the category.
Short version: the newest, most effective molecule in the metabolic class, with grade-A randomized human data behind it. Available compounded under a clinician, and, like all compounded medicines, not FDA-approved.
Can you actually get it?
Plain-English verdict: Available.
Regulatory status: FDA-approved (branded) · 503A compounded · Available now.
Available now through a clinician. Branded versions are FDA-approved; compounded tirzepatide is not FDA-approved and supply is constrained, eligibility is a clinical decision.
How does Tirzepatide work?
A dual agonist at both GIP and GLP-1 receptors, amplifying satiety and glycemic effects beyond a GLP-1 alone.
What it does — and what it does not do
What it does: Supports the largest average weight loss and metabolic improvement seen in randomized trials to date.
What it does not do: It is not a guaranteed result and not a substitute for the habits that keep the loss; compounded forms are not FDA-approved.
How honest is the evidence?
Evidence grade A — large randomized controlled trials (SURMOUNT / SURPASS). Read our grading methodology for what each grade means.
What we still don't know: Head-to-head long-term outcome data is still maturing; compounded-formulation specifics differ from the studied branded product.
WADA status: Not prohibited.
How it is taken
What the literature reports: weekly subcutaneous, titrated. Educational only, never an instruction to self-administer.
Who should not take it
Personal/family history of medullary thyroid carcinoma or MEN-2; pregnancy. GI tolerability is dose-dependent.
Sources
Jastreboff et al., SURMOUNT-1 (NEJM 2022) · FDA labeling (Zepbound/Mounjaro)
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.